# Nafcillin

NDC: 63323-330
Generic name: NAFCILLIN
Labeler / Manufacturer: Fresenius Kabi USA, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, POWDER, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20110427

FDA application: ANDA090005

## Active ingredients

- NAFCILLIN SODIUM: 10 g/100mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"63323-330"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=63323-330
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bbf0d8e4-b8e4-4958-b6b6-f0b9960f3b6a